Cite
HARVARD Citation
Akinosoglou, K. et al. (2023). Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial. EClinicalMedicine. p. . [Online].